Antimalarial Activity of KAF156 in Falciparum and Vivax Malaria (Q33435505)

26 July 2017

Antimalarial Activity of KAF156 in Falciparum and Vivax Malaria (English)

1 reference

26 July 2017

0 references

0 references

Plasmodium falciparum

0 references

0 references

Aung P Phyo

5

0 references

Nicholas John White

1

Nicholas J White

1 reference

26 July 2017

4

François Nosten

1 reference

Borimas Hanboonkunupakarn

26 July 2017

6

Borimas Hanboonkunupakarn

1 reference

26 July 2017

Sasithon Pukrittayakamee

7

Sasithon Pukrittayakamee

1 reference

26 July 2017

8

Podjanee Jittamala

1 reference

26 July 2017

13

Baldur Magnusson

1 reference

26 July 2017

Thierry Tidiane Diagana

18

Thierry T Diagana

1 reference

26 July 2017

20

F Joel Leong

1 reference

26 July 2017

Tran T Duong

2

1 reference

26 July 2017

Chirapong Uthaisin

3

1 reference

26 July 2017

Kittiphum Chuthasmit

9

1 reference

26 July 2017

Ming S Cheung

10

1 reference

26 July 2017

Yiyan Feng

11

1 reference

26 July 2017

Ruobing Li

12

1 reference

26 July 2017

Marc Sultan

14

1 reference

26 July 2017

Daniela Wieser

15

1 reference

26 July 2017

Xiaolei Xun

16

1 reference

26 July 2017

Rong Zhao

17

1 reference

26 July 2017

Peter Pertel

19

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 September 2016

1 reference

The New England Journal of Medicine

26 July 2017

1 reference

26 July 2017

375

1 reference

26 July 2017

1152-1160

1 reference

26 July 2017

12

1 reference

Evidence of Plasmodium falciparum Malaria Multidrug Resistance to Artemisinin and Piperaquine in Western Cambodia: Dihydroartemisinin-Piperaquine Open-Label Multicenter Clinical Assessment

26 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142602

Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142602

A first-in-human randomized, double-blind, placebo-controlled, single- and multiple-ascending oral dose study of novel Imidazolopiperazine KAF156 to assess its safety, tolerability, and pharmacokinetics in healthy adult volunteers

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142602

Spread of artemisinin resistance in Plasmodium falciparum malaria

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142602

Spiroindolone KAE609 for falciparum and vivax malaria

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142602

KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142602

A molecular marker of artemisinin-resistant Plasmodium falciparum malaria

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142602

Malaria burden and artemisinin resistance in the mobile and migrant population on the Thai-Myanmar border, 1999-2011: an observational study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142602

Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142602

The parasite clearance curve

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142602

Artemisinin resistance: current status and scenarios for containment

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142602

Artemisinin Resistance in Plasmodium falciparum Malaria

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142602

Naphthoquine phosphate and its combination with artemisinine

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142602

Efficacy of naphthoquine, artemisinine and a combination of the two drugs in the treatment of falciparum malaria

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142602

Artemisinin derivatives for treating uncomplicated malaria

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142602

Artemisinin resistance is a clear and present danger

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5142602

31 October 2018

Identifiers

DOI

10.1056/NEJMOA1602250

1 reference

26 July 2017

1 reference

26 July 2017

1 reference